Pathway maps

Cholesterol and Sphingolipids transport / Generic schema (normal and CF)
Cholesterol and Sphingolipids transport / Generic schema (normal and CF)

Object List (links open in MetaCore):

Cholesterol vesicle, 3.1.1.13, 2.3.1.9, Cholesterol outer leaflet, NPC1, Cholesterol Golgi membrane, NPC2, 3.1.1.13, Cholesterol extracellular region, Sphingolipids, 3.1.1.13, Sphingolipids TGN, Cholesteryl esters cytosol, Cholesterol TGN membrane, 3.1.1.13, Cholesteryl ester extracellular region, Sphingolipids vesicle, Cholesteryl ester endoplasmic reticulum, Cholesteryl ester vesicle, Cholesterol endoplasmic reticulum, Cholesterol inner leaflet, Cholesteryl ester lysosome, Sphingolipids, Sphingolipids plasma membrane, Cholesterol vesicle, Sphingolipids vesicle, Sphingolipids vesicle, Cholesteryl ester vesicle, Cholesterol plasma membrane, Cholesterol plasma membrane , Sphingolipids Golgi membrane, Cholesterol lysosome, Cholesterol cytoplasm, Cholesterol mitochondrial, Cholesterol vesicle, Cholesterol vesicle, Sphingolipids plasma membrane

Description

Cholesterol and Sphingolipid transport/ Generic scheme (normal and CF)

CF pathway (highlighted in purple on map)

Cultured models of CF epithelial cells show intracellular accumulation of unesterified Cholesterol in a manner similar to Niemann-Pick disease and resulting in free Cholesterol accumulation in late endosomes and lysosomes [1], [2], [3]. Increased Cholesterol and Sphingolipids in punctate endosomal structures indicates a block in the translocation of Cholesterol to the ER. It prevents Cholesterol esterification and store in the lipid droplets [2]. Also it prevents Cholesterol biosynthesis inhibition and promotes Cholesterol biosynthesis de novo and ER-to-Golgi vesicle traffic [1], [4], [5]. An indirect marker of increased de novo Cholesterol synthesis is increased plasma membrane Cholesterol content in CF cells and tissues determined by electrochemical measurement [1], [6]. Rab-9 overexpression clears the punctate Cholesterol accumulations, and this might be the consequence of Rab-9 overcoming an endosome-to-Golgi Cholesterol trafficking block in C F cells [2]. For instance, 3-hydroxy-3-methylglutaryl-Coenzyme A reductase inhibitor lovastatin reduces cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (CFTR)-mediated chloride transport and CFTR trafficking to the apical membrane [7]. Alterations in Cholesterol processing in CF cells may be viewed as an adaptive mechanism for increasing the content of CFTR at the plasma membrane [1].

Normal pathway

Cholesterol and Cholesteryl ester bound to lipoprotein particles are recognized by the corresponding receptors [8], [9], [10], [11]. Cholesterol receptors are selected for internalization into clathrin-coated pits and transported to sorting endosomes. Sphingolipid -containing membranes are internalized via caveolae-raft or clathrin-dependent pathways [12].

Internalized in early endosomes, High density lipoprotein ( HDL)-Cholestryl ester is hydrolyzed there by neutral cholesteryl ester hydrolase, unlike low density lipoprotein LDL-Cholesteryl ester [13], [14]. Further lipid sorting from early endosomes to sorting endosomes is mediated by members of the RAS oncogene family in in both clathrin pits and vesicles. Rab-independent sorting also occurs in caveolae endosomes [15].

Lipids return to the cell surface via a conventional, tubulo-vesicular membrane recycling pathway. In contrast, Cholesterol can move from the plasma membrane to the ERC by a non-vesicular, ATP-independent process. Soluble cytosolic proteins carry Cholestero l from internal membranes to plasmalemma, specifically to caveolae-lipid rafts [16], [17], [18]. As a result, ERC is one of the most Cholesterol -rich compartments in the cell [19].

Cholesterol can be transported from early to late endosomes and late endosomes to lysosomes. Rab-9 is believed to regulate the late step of Cholesterol transport from endosomes to the trans -Golgi network (TGN) [19]. Sphingolipids are sorted preferentially to TGN [12], but Cholesterol and, especially, Cholesteryl ester can be sorted to TGN and to lysosome. In lysosomes, acid cholesterol esterase hydrolyses Cholesteryl ester to free Cholesterol and fatty acids [20]. Sphingolipid activator proteins promote Sphingolipids degradation by lysosomal enzymes [21].

Exchange of Cholestrol content between late endosomes and lysosomes depends upon the ongoing tubulovesicular late endocytic trafficking. Tubulovesicular traffic not only mediates Cholesterol efflux from the late endosome membrane inner leaflet to the outer leaflet, but also promotes formation of tubules with Cholesterol from lysosomes and late endosomes toward other intracellular membranes especially trans-Golgi network (TGN) [22], [23], [24], [25].

Niemann-Pick disease, type C1 and C2 proteins ( NPC1 and NPC2 ) promote Cholesterol efflux presumably via direct interaction with the acceptor membrane. Transfer of Cholesterol to membranes is accelerated in the acidic environment [26].

StAR-related lipid transfer domain containing proteins may capture Cholesterol via their MENTAL domain in the late-endosomal membranes, and then Cholesterol can be transferred to the cytosolic acceptor protein or the membrane. Cholesterol transfer from other donor to acceptor vesicles has been shown to involve proteins with the START domain. [27], [28], [25].

Soluble cytosolic proteins like sterol promote Cholesterol transfer from the lysosome membrane to the outer mitochondrial membrane [29]. Thus, these proteins promote non-vesicle intracellular Cholesterol transport between intracellular membranes (endosomes, lysosome, endoplasmic reticulum (ER), complex Golgi etc.), cytosolic Chiolesterol/Cholesteryl ester pool, lipid droplets, and probably to the inner leaflet of plasma membrane [30], [31], [28], [32], [25].

Lipid rafts, caveolae or transport vesicles containing Cholesterol/Sphingolipids -rich membrane patches are formed in TGN. TGN receives Sphingolipids and Cholesterol from carriers, endosomes, lipid droplets, or ER. Pool of Sphingolipids is enriched by newly synthesized sphingomyelin. These lipid-rich structures move to the apical plasma membrane [33], [34], [35]. Unlike Cholesterol, Sphingomyelin is transported to the apical membrane preferentially by vesicles [36].

De novo-synthesized Cholestero l in the ER is transported directly to the PM by non-vesicular processes. However, some cholesterol and de novo synthesized Sphingomyelin follow the pathway from the ER to the Golgi and then to the plasma membrane. Non-vesicular transport from ER to PM proceeds via cytosolic Heat-shock protein/Caveolin/Chaperone/Lipid complex [37], [17].

Excess Cholesterol in the ER is esterified and the esters are stored in cytoplasmic lipid droplets [38]. Cholesteryl ester transfer protein can transport Cholesteryl ester into storage droplets [39].

Since both TGN and ERC are engaged in extensive membrane traffic, esterification of Cholesterol in these membranes may play an important role [40].

Lipid vesicle retrograde pathway from Golgi to ER is still being investigated. Cholesterol and other raft lipids are most probably not transported between the Golgi apparatus and ER this way [41].

Soluble cytosolic sterol carrier proteins transport Cholesterol to inner leaflet of PM. ATP-binding cassette family members transport mediate accumulation of Cholestero l in the outer leaflets by transporting the lipid from the inner leaflets [42], [43], [44].

References:

  1. White NM, Jiang D, Burgess JD, Bederman IR, Previs SF, Kelley TJ
    Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis. American journal of physiology. Lung cellular and molecular physiology 2007 Feb;292(2):L476-86
  2. Gentzsch M, Choudhury A, Chang XB, Pagano RE, Riordan JR
    Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking. Journal of cell science 2007 Feb 1;120(Pt 3):447-55
  3. Lim CH, Bijvelds MJ, Nigg A, Schoonderwoerd K, Houtsmuller AB, de Jonge HR, Tilly BC
    Cholesterol depletion and genistein as tools to promote F508delCFTR retention at the plasma membrane. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2007;20(5):473-82
  4. Bengoechea-Alonso MT, Ericsson J
    SREBP in signal transduction: cholesterol metabolism and beyond. Current opinion in cell biology 2007 Feb 13;
  5. Ikonen E
    Cellular cholesterol trafficking and compartmentalization. Nature reviews. Molecular cell biology 2008 Feb;9(2):125-38
  6. Jiang D, Fang D, Kelley TJ, Burgess JD
    Electrochemical analysis of cell plasma membrane cholesterol at the airway surface of mouse trachea. Analytical chemistry 2008 Feb 15;80(4):1235-9
  7. Shen BQ, Widdicombe JH, Mrsny RJ
    Effects of lovastatin on trafficking of cystic fibrosis transmembrane conductance regulator in human tracheal epithelium. The Journal of biological chemistry 1995 Oct 20;270(42):25102-6
  8. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T
    Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. The Journal of biological chemistry 1995 Jun 30;270(26):15747-54
  9. Kwiterovich PO Jr
    The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. The American journal of cardiology 2000 Dec 21;86(12A):5L-10L
  10. Espirito Santo SM, Rensen PC, Goudriaan JR, Bensadoun A, Bovenschen N, Voshol PJ, Havekes LM, van Vlijmen BJ
    Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice. Journal of lipid research 2005 Jun;46(6):1097-102
  11. Ruiz J, Kouiavskaia D, Migliorini M, Robinson S, Saenko EL, Gorlatova N, Li D, Lawrence D, Hyman BT, Weisgraber KH, Strickland DK
    The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. Journal of lipid research 2005 Aug;46(8):1721-31
  12. Choudhury A, Dominguez M, Puri V, Sharma DK, Narita K, Wheatley CL, Marks DL, Pagano RE
    Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. The Journal of clinical investigation 2002 Jun;109(12):1541-50
  13. Connelly MA, Kellner-Weibel G, Rothblat GH, Williams DL
    SR-BI-directed HDL-cholesteryl ester hydrolysis. Journal of lipid research 2003 Feb;44(2):331-41
  14. Xie C, Richardson JA, Turley SD, Dietschy JM
    Cholesterol substrate pools and steroid hormone levels are normal in the face of mutational inactivation of NPC1 protein. Journal of lipid research 2006 May;47(5):953-63
  15. Sharma DK, Choudhury A, Singh RD, Wheatley CL, Marks DL, Pagano RE
    Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling. The Journal of biological chemistry 2003 Feb 28;278(9):7564-72
  16. Hao M, Lin SX, Karylowski OJ, Wustner D, McGraw TE, Maxfield FR
    Vesicular and non-vesicular sterol transport in living cells. The endocytic recycling compartment is a major sterol storage organelle. The Journal of biological chemistry 2002 Jan 4;277(1):609-17
  17. Holtta-Vuori M, Ikonen E
    Endosomal cholesterol traffic: vesicular and non-vesicular mechanisms meet. Biochemical Society transactions 2006 Jun;34(Pt 3):392-4
  18. Schroeder F, Atshaves BP, McIntosh AL, Gallegos AM, Storey SM, Parr RD, Jefferson JR, Ball JM, Kier AB
    Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. Biochimica et biophysica acta 2007 Jun;1771(6):700-18
  19. Takahashi M, Murate M, Fukuda M, Sato SB, Ohta A, Kobayashi T
    Cholesterol controls lipid endocytosis through Rab11. Molecular biology of the cell 2007 Jul;18(7):2667-77
  20. Sugii S, Reid PC, Ohgami N, Du H, Chang TY
    Distinct endosomal compartments in early trafficking of low density lipoprotein-derived cholesterol. The Journal of biological chemistry 2003 Jul 18;278(29):27180-9
  21. Sandhoff K, Klein A
    Intracellular trafficking of glycosphingolipids: role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion. FEBS letters 1994 Jun 6;346(1):103-7
  22. Higgins ME, Davies JP, Chen FW, Ioannou YA
    Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Molecular genetics and metabolism 1999 Sep;68(1):1-13
  23. Zhang M, Dwyer NK, Love DC, Cooney A, Comly M, Neufeld E, Pentchev PG, Blanchette-Mackie EJ, Hanover JA
    Cessation of rapid late endosomal tubulovesicular trafficking in Niemann-Pick type C1 disease. Proceedings of the National Academy of Sciences of the United States of America 2001 Apr 10;98(8):4466-71
  24. Chang TY, Chang CC, Ohgami N, Yamauchi Y
    Cholesterol sensing, trafficking, and esterification. Annual review of cell and developmental biology 2006;22:129-57
  25. Prinz WA
    Non-vesicular sterol transport in cells. Progress in lipid research 2007 Nov;46(6):297-314
  26. Infante RE, Wang ML, Radhakrishnan A, Kwon HJ, Brown MS, Goldstein JL
    NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proceedings of the National Academy of Sciences of the United States of America 2008 Oct 7;105(40):15287-92
  27. Alpy F, Tomasetto C
    MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochemical Society transactions 2006 Jun;34(Pt 3):343-5
  28. Miller WL
    Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochimica et biophysica acta 2007 Jun;1771(6):663-76
  29. Gallegos AM, Schoer JK, Starodub O, Kier AB, Billheimer JT, Schroeder F
    A potential role for sterol carrier protein-2 in cholesterol transfer to mitochondria. Chemistry and physics of lipids 2000 Mar;105(1):9-29
  30. Wustner D, Herrmann A, Hao M, Maxfield FR
    Rapid nonvesicular transport of sterol between the plasma membrane domains of polarized hepatic cells. The Journal of biological chemistry 2002 Aug 16;277(33):30325-36
  31. Rodriguez-Agudo D, Ren S, Hylemon PB, Montanez R, Redford K, Natarajan R, Medina MA, Gil G, Pandak WM
    Localization of StarD5 cholesterol binding protein. Journal of lipid research 2006 Jun;47(6):1168-75
  32. de Donato G, Gussoni G, de Donato G, Cao P, Setacci C, Pratesi C, Mazzone A, Ferrari M, Veglia F, Bonizzoni E, Settembrini P, Ebner H, Martino A, Palombo D
    Acute limb ischemia in elderly patients: can iloprost be useful as an adjuvant to surgery? Results from the ILAILL study. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2007 Aug;34(2):194-8
  33. Heino S, Lusa S, Somerharju P, Ehnholm C, Olkkonen VM, Ikonen E
    Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proceedings of the National Academy of Sciences of the United States of America 2000 Jul 18;97(15):8375-80
  34. Godi A, Di Campli A, Konstantakopoulos A, Di Tullio G, Alessi DR, Kular GS, Daniele T, Marra P, Lucocq JM, De Matteis MA
    FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nature cell biology 2004 May;6(5):393-404
  35. Tagawa A, Mezzacasa A, Hayer A, Longatti A, Pelkmans L, Helenius A
    Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. The Journal of cell biology 2005 Aug 29;170(5):769-79
  36. Boehm S
    Selective inhibition of M-type potassium channels in rat sympathetic neurons by uridine nucleotide preferring receptors. British journal of pharmacology 1998 Jul;124(6):1261-9
  37. Uittenbogaard A, Ying Y, Smart EJ
    Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. The Journal of biological chemistry 1998 Mar 13;273(11):6525-32
  38. Liu J, Chang CC, Westover EJ, Covey DF, Chang TY
    Investigating the allosterism of acyl-CoA:cholesterol acyltransferase (ACAT) by using various sterols: in vitro and intact cell studies. The Biochemical journal 2005 Oct 15;391(Pt 2):389-97
  39. Izem L, Morton RE
    Possible role for intracellular cholesteryl ester transfer protein in adipocyte lipid metabolism and storage. The Journal of biological chemistry 2007 Jul 27;282(30):21856-65
  40. Khelef N, Soe TT, Quehenberger O, Beatini N, Tabas I, Maxfield FR
    Enrichment of acyl coenzyme A:cholesterol O-acyltransferase near trans-golgi network and endocytic recycling compartment. Arteriosclerosis, thrombosis, and vascular biology 2000 Jul;20(7):1769-76
  41. Fullekrug J, Simons K
    Lipid rafts and apical membrane traffic. Annals of the New York Academy of Sciences 2004 Apr;1014:164-9
  42. Chen W, Sun Y, Welch C, Gorelik A, Leventhal AR, Tabas I, Tall AR
    Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. The Journal of biological chemistry 2001 Nov 23;276(47):43564-9
  43. Gadsby DC, Vergani P, Csanady L
    The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 2006 Mar 23;440(7083):477-83
  44. Ghering AB, Davidson WS
    Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein A-I. Journal of lipid research 2006 Dec;47(12):2781-8